← Atlas Theme · spans 1 topics
Geopolitical rivalry forces sovereign regulators to overhaul early-stage clinical trial trial structures.
To prevent clinical research and pharmaceutical pipelines from migrating to global competitors like China, home states are introducing expedited pilot pathways and pilot programs.
1
Topics it spans
2
Findings citing it
—
Evidence window
The convergence
The same conclusion keeps arriving from across the workspace's research — 1 topics independently instantiate this theme. Filter the evidence by where it came from:
Science & Health
HHS and FDA's "Operation Trialblazer": Accelerating Clinical Trials and Early-Stage Development The FDA's Operation Trialblazer seeks to counter the competitive threat of China overhauling its own early-stage trial frameworks to draw clinical research overseas.
Science & Health
HHS and FDA's "Operation Trailblazer": Accelerating Clinical Trials and Early-Stage Development The FDA's proposed pilot program seeks to overhaul and speed up early-stage clinical trial entries to keep the US competitive.